Kilian Kelly, Chief Executive Officer & Managing Director at Cynata Therapeutics Limited, holds 619.65K shares in Cynata Therapeutics Limited (Ticker: CYYNF). Most recently, Kilian Kelly Bought $94,143 shares of Cynata Therapeutics Limited on Nov 22, 2023 for an estimated value of 12.44K.

See the Hottest Stocks Based on Insider Trading >

Kilian Kelly
Cynata Therapeutics Limited (CYYNF)
Chief Executive Officer & Managing Director

Not Ranked

Kilian Kelly has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

CYYNF

A breakdown of Kilian Kelly's holdings

See the Top Stocks by Insiders

Insider Roles

Cynata Therapeutics Limited
(CYYNF)

Chief Executive Officer & Managing Director

Roles that Kilian Kelly holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Currently, no data available

The most profitable trade made by Kilian Kelly

See the Latest Stocks Traded by Insiders

Kilian Kelly's Trading History

CYYNF

Cynata Therapeutics Limited

Nov 22, 2023

Chief Executive Officer & Managing Director

Informative Buy

12.44K

$68.16K

Nov 22, 2023

Informative Buy

AU$12.44K

AU$0.13

―

List of latest transactions for each holding click on a transaction to see Kilian Kelly's performance on stock

See All Insider Trading from Today

Kilian Kelly insider profile FAQ

What is the percentage of profitable transactions made by Kilian Kelly?

The percentage of profitable transactions made by Kilian Kelly is ―.

What is the average return per transaction made by Kilian Kelly?

The average return per transaction made by Kilian Kelly is ―.

What stocks does Kilian Kelly hold?

Kilian Kelly holds: CYYNF stocks.

What was Kilian Kelly’s latest transaction?

Kilian Kelly latest transaction was an Informative Buy of $12.44K.

What was Kilian Kelly's most profitable transaction?

Kilian Kelly’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.

What is Kilian Kelly's role in Cynata Therapeutics Limited?

Kilian Kelly's role in Cynata Therapeutics Limited is Chief Executive Officer & Managing Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Kilian Kelly Insider Profile

Kilian Kelly Cynata Therapeutics Limited (CYYNF)Chief Executive Officer & Managing Director